Literature DB >> 27032874

Active recruitment and limited participant-load related to high participation in large population-based biobank studies.

Sander K R van Zon1, Salome Scholtens2, Sijmen A Reijneveld3, Nynke Smidt4, Ute Bültmann3.   

Abstract

OBJECTIVES: Insight into baseline participation rates and their determinants is crucial for designing future population-based biobank studies. We therefore conducted a systematic review and meta-analysis of baseline participation rates and their determinants in large longitudinal population-based biobank studies. STUDY DESIGN AND
SETTING: We screened studies registered within the Public Population Project in Genomics and Society and in the Biobanking and Biomolecular Resources Research Infrastructure catalogues to find potentially eligible studies. We retrieved data with regard to participation rate, biobank design, performed measurements, and specific strategies for improving participation. We calculated weighted pooled proportions for each determinant using random-effects models.
RESULTS: We included 25 studies (participation rates 5-96%). Participation rates were highest for studies involving face-to-face recruitment [82.6%; 95% confidence interval (CI): 72.2%, 90.9%], for studies in which participants were visited for an examination (77.5%; 95% CI: 64.0%, 88.6%) and for studies in which at maximum four measurements were performed (78.2%; 95% CI: 69.7%, 85.7%). Specific strategies to improve participation were not found to be associated with higher participation rates.
CONCLUSION: Specific choices of recruitment methods and design have consequences for participation rates. These insights may help to increase participation in future studies, thereby enhancing the validity of their findings.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Determinants; Meta-analysis; Participation; Population-based biobank; Response; Review

Mesh:

Year:  2016        PMID: 27032874     DOI: 10.1016/j.jclinepi.2016.03.009

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  6 in total

1.  The effect of home visits as an additional recruitment step on the composition of the final sample: a cross-sectional analysis in two study centers of the German National Cohort (NAKO).

Authors:  Lilian Krist; Ahmed Bedir; Julia Fricke; Alexander Kluttig; Rafael Mikolajczyk
Journal:  BMC Med Res Methodol       Date:  2021-08-23       Impact factor: 4.615

2.  Motivations for (non)participation in population-based health studies among the elderly - comparison of participants and nonparticipants of a prospective study on influenza vaccination.

Authors:  Manas K Akmatov; Leonhard Jentsch; Peggy Riese; Marcus May; Malik W Ahmed; Damaris Werner; Anja Rösel; Jana Prokein; Inga Bernemann; Norman Klopp; Blair Prochnow; Thomas Illig; Christoph Schindler; Carlos A Guzman; Frank Pessler
Journal:  BMC Med Res Methodol       Date:  2017-02-02       Impact factor: 4.615

3.  Questioning the rhetoric of a 'willing population' in Finnish biobanking.

Authors:  Karoliina Snell; Heta Tarkkala
Journal:  Life Sci Soc Policy       Date:  2019-05-27

4.  Strategies to Enhance Retention in a Cohort Study Among Adults of Turkish Descent Living in Berlin.

Authors:  Christina Dornquast; Thomas Reinhold; Saliha Solak; Melike Durak; Heiko Becher; Burgi Riens; Katja Icke; Ina Danquah; Stefan N Willich; Thomas Keil; Lilian Krist
Journal:  J Immigr Minor Health       Date:  2021-11-19

5.  Effect of an eHealth Intervention to Reduce Sickness Absence Frequency Among Employees With Frequent Sickness Absence: Randomized Controlled Trial.

Authors:  Annette Notenbomer; Corné Roelen; Johan Groothoff; Willem van Rhenen; Ute Bültmann
Journal:  J Med Internet Res       Date:  2018-10-23       Impact factor: 5.428

6.  How Semantics Connotations May Influence Concerns About Donation of Biospecimens.

Authors:  Stacey A Page; Beverly Anne Collisson; Jenny Godley; Danny Nguyen; Luanne Metz; Daniel Muruve
Journal:  Biopreserv Biobank       Date:  2020-11-11       Impact factor: 2.256

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.